Dr. Kristin Marie Torre, MD

Dr. Torre practices at Connecticut Skinhealth in Shelton, Connecticut.

Dr. Torre's NPI, 1760944896, was assigned on April 6, 2019. Dr. Torre graduated from University of Connecticut in 2019. Dr. Torre holds Connecticut license 73926.

Dr. Torre's primary practice is Connecticut Skinhealth, at 4 Corporate Dr, Shelton, CT 06484 in Greater Bridgeport County. The practice phone is (203) 538-5685.

Dr. Torre's primary practice is Connecticut Skinhealth in Shelton, Connecticut. Dr. Torre is also affiliated with Griffin Hospital. The medical group on file is Dermatology Physicians of Connecticut. Dmand AI also links Dr. Torre to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Torre practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Torre's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Torre is licensed in Connecticut.

CMS data shows 1,320 Medicare services from Dr. Torre across 10 procedure codes in 2024, for 321 Medicare patients. Medicare paid $60,050 for them. Every service was in an office.

CMS counts 321 Medicare patients who saw Dr. Torre in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Torre's median patient age at 63, with 62% women.

In 2024, Dr. Torre wrote 828 Medicare Part D claims for 356 patients. 85% of them were for generic drugs. CMS names the drug for 678 of them, across 14 drugs with 11 or more claims each, at $187,469 in total drug cost. In 2023, CMS named 90 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Torre for performance year 2024, reported as part of a group. Dr. Torre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 461 procedures of removal of skin lesions by Dr. Torre, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Torre, published from 2016 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Biomarkers, Tumor, Skin Neoplasms and Dermatology. Dr. Torre has published most often in JAAD Case Rep. Dr. Torre's most frequent co-authors are Marti J. Rothe, MD, Michael Murphy, MD and Rohit Singh, MD.

CMS Open Payments shows 385 general payments to Dr. Torre from 23 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 54% of the total. Incyte Corporation paid the most, $9,560.

Dr. Torre graduated from University of Connecticut in 2019.